IL-6、IL-10与TNFα和认知结局的横断面及纵向关联:Mayo衰老研究
在Mayo衰老研究纳入的1602名社区居住老年人(中位年龄72.8岁)中,基线血浆IL-6、IL-10、TNFα及IL-6/IL-10比值与认知测验表现无横断面关联,但IL-6和IL-10较高者MCI诊断比值更高。纵向随访未发现这些炎症因子与认知测验表现或MCI风险相关,提示血浆炎症标志物在一般人群中可能不适用于判定认知下降与MCI风险。
要点
- 横断面分析中炎症因子与总体及领域特异性认知z评分无关联。
- 横断面分析中IL-6、IL-10较高与MCI诊断比值升高相关。
- 纵向分析未见炎症因子与认知表现或MCI风险相关。
核心结论
- 血浆炎症标志物在一般人群中可能不适用于判定认知下降和MCI的风险。
研究设计与样本
- Mayo衰老研究对1602名社区居住老年人(中位年龄72.8岁)进行横断面与纵向分析,随访间隔15个月。
主要发现
- 横断面多变量分析未观察到炎症因子水平与总体或领域特异性认知z评分相关。
- 横断面分析中IL-6和IL-10水平较高与MCI诊断比值升高相关。
- 纵向未观察到炎症因子与认知测验表现或MCI风险相关。
- 性别、年龄、认知状态、APOE ε4、糖尿病、抑郁和脑淀粉样蛋白沉积均非效应修饰因素。
临床怎么用
- 不应仅凭血浆IL-6、IL-10、TNFα水平评估社区老年人的认知下降或MCI风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic inflammation has been linked with geriatric-related conditions, including dementia. Inflammatory cytokine levels, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) α, in the blood have been associated with cognitive impairment and decline. However, evidence has been mixed. METHODS: We examined the cross-sectional and longitudinal associations between baseline-measured IL-6, IL-10, and TNFα levels and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive impairment (MCI) among 1,602 community-dwelling older adults (median age = 72.8) enrolled in the Mayo Clinic Study of Aging. Approximately half (46.5%) of participants were female and 98.6% were white. At baseline and follow-up visits (occurring at 15-month intervals), participants completed neuropsychological testing, blood draws, and had a clinical consensus diagnosis. RESULTS: In multivariable cross-sectional analyses, we did not observe an association between inflammatory cytokine levels and global or domain-specific cognitive z scores; however, higher IL-6 and IL-10 levels were associated with greater odds of a MCI diagnosis. Longitudinally, we did not observe any association between inflammatory cytokine levels and cognitive test performance or risk of MCI. Sex, age, cognitive status, APOE ε4 genotype, diabetes, depression, and cerebral amyloid-beta deposition were not effect modifiers. CONCLUSIONS: These results suggest that plasma inflammatory markers may not be useful to ascertain risk for cognitive decline and MCI in the general population.
引用
- Wennberg AMV, Hagen CE, Machulda MM, et al. The Cross-sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30256904. doi:10.1093/gerona/gly217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。